Centennial Wealth Advisory
ABBV icon

Centennial Wealth Advisory’s AbbVie ABBV Stock Holding History

Centennial Wealth Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$613K Buy
2,340
+9
+0.4% +$2.31K 0.13% 119
2026
Q2 		$587K Buy
2,331
+77
+3% +$16.6K 0.13% 114
2026
Q1 		$491K Buy
2,254
+137
+6% +$30.4K 0.12% 105
2025
Q4 		$484K Buy
2,117
+28
+1% +$6.38K 0.13% 114
2025
Q3 		$484K Buy
2,089
+45
+2% +$9.16K 0.13% 109
2025
Q2 		$381K Sell
2,044
-65
-3% -$12.1K 0.12% 118
2025
Q1 		$442K Buy
2,109
+80
+4% +$15.6K 0.16% 90
2024
Q4 		$361K Sell
2,029
-169
-8% -$31.1K 0.14% 99
2024
Q3 		$434K Buy
2,198
+471
+27% +$87.9K 0.17% 76
2024
Q2 		$296K Buy
1,727
+368
+27% +$61K 0.13% 101
2024
Q1 		$248K Buy
+1,359
New +$234K 0.11% 121

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Sepio Capital
Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Ferguson Wellman Capital Management
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Centennial Wealth Advisory's ABBV Position: Q3 2026 in Review

Centennial Wealth Advisory increased its AbbVie (ABBV) stake by 0.39% in Q3 2026, buying an estimated $2.31K and bringing the position to 2,340 shares worth $613K. The position accounts for 0.13% of the portfolio, ranked #119.

Centennial Wealth Advisory first reported a position in ABBV in Q1 2024 and has held it in 11 quarters since. 1,323 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Centennial Wealth Advisory held 2,340 shares of AbbVie worth $613K as of Q3 2026.
  • Centennial Wealth Advisory bought 9 AbbVie shares in Q3 2026, an estimated $2.31K.
  • AbbVie made up 0.13% of Centennial Wealth Advisory's portfolio in Q3 2026, its #119 holding.
  • Centennial Wealth Advisory first reported a position in AbbVie in Q1 2024 and has held it in 11 quarters since.
  • 1,323 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Centennial Wealth Advisory's 13F filing for Q3 2026, filed 16 Oct 2026.